LRLilian Cristina Russo

Lilian Cristina Russo

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Lilian Cristina Russo has a total of 94 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Long Noncoding RNA LINC00941 Links Oncogenic KRAS Signaling to Aggressiveness, DNA Repair, and Chemoresistance in Pancreatic Cancer

    by Thalita Bueno Corrêa, Gabriel Lucas da Fonseca, Rauni Borges Marques, Sandro Mascena Gomes‐Filho, Lutero Augusto Hasenkamp, Yuli Thamires Magalhães, Lillian Cristina Russo Vieira, Nicolas Paulino Rezende, Stefany Cristine Rodrigues da Silva, Nicolas Carlos Hoch, et al.

    Oncogenic KRAS mutations are the primary drivers of pancreatic ductal adenocarcinoma (PDAC), but the noncoding landscape downstream of KRAS remains to be fully elucidated. Here, by integrating PDAC RNA sequencing and exome data from The Cancer Genome Atlas (TCGA), we identified 49 long intergenic noncoding RNAs (lincRNAs) differentially expressed according to KRAS mutation status. Among these, LINC00941 emerged as a primary candidate, as its expression is regulated by KRAS in both loss‐ and gain‐of‐function models and is significantly upregulated in PDAC tumors. Analysis of single‐cell RNA sequencing and clinical datasets (TCGA/ICGC) revealed that LINC00941 is significantly enriched in PDAC malignant epithelial cells and correlates with poor PDAC patient prognosis. Functional assays demonstrated that LINC00941 knockdown impairs PDAC cell migration and invasion. Notably, LINC00941‐depleted cells exhibit delayed DNA repair following irradiation, as shown by the slower resolution of radiation‐induced DNA strand breaks, and increased sensitivity to gemcitabine‐induced apoptosis. Transcriptomic and RT‐qPCR analyses associated the loss of LINC00941 with a significant reduction in key DNA repair and survival‐related genes, including BACH1, TOP2A, and BIRC5. These findings suggest that LINC00941 is required to maintain genomic stability and promote survival under therapeutic stress in KRAS‐driven cells. In conclusion, our study identifies a novel KRAS/LINC00941 axis that supports a pro‐survival and chemoresistant phenotype in PDAC, positioning LINC00941 as a mediator of the DNA damage response and a potential therapeutic target in PDAC.

  • Open Access

    PARP14 is regulated by the PARP9/DTX3L complex and promotes interferon γ-induced ADP-ribosylation

    by Victoria Chaves Ribeiro, Lilian Cristina Russo, Nícolas Carlos Hoch

    Protein ADP-ribosylation plays important but ill-defined roles in antiviral signalling cascades such as the interferon response. Several viruses of clinical interest, including coronaviruses, express hydrolases that reverse ADP-ribosylation catalysed by host enzymes, suggesting an important role for this modification in host-pathogen interactions. However, which ADP-ribosyltransferases mediate host ADP-ribosylation, what proteins and pathways they target and how these modifications affect viral infection and pathogenesis is currently unclear. Here we show that host ADP-ribosyltransferase activity induced by IFNγ signalling depends on PARP14 catalytic activity and that the PARP9/DTX3L complex is required to uphold PARP14 protein levels via post-translational mechanisms. Both the PARP9/DTX3L complex and PARP14 localise to IFNγ-induced cytoplasmic inclusions containing ADP-ribosylated proteins, and both PARP14 itself and DTX3L are likely targets of PARP14 ADP-ribosylation. We provide evidence that these modifications are hydrolysed by the SARS-CoV-2 Nsp3 macrodomain, shedding light on the intricate cross-regulation between IFN-induced ADP-ribosyltransferases and the potential roles of the coronavirus macrodomain in counteracting their activity.


  • DUSP3 maintains genomic stability and cell proliferation by modulating NER pathway and cell cycle regulatory proteins

    by Lilian Cristina Russo, Jessica Oliveira Farias, Fabio Luis Forti

    The DUSP3 phosphatase regulates cell cycle, proliferation, apoptosis and senescence of different cell types, lately shown as a mediator of DNA repair processes. This work evaluated the impact of DUSP3 loss of function (lof) on DNA repair-proficient fibroblasts (MRC-5), NER-deficient cell lines (XPA and XPC) and translesion DNA synthesis (TLS)-deficient cells (XPV), after UV-radiation stress. The levels of DNA strand breaks, CPDs and 6-4-PPs have accumulated over time in all cells under DUSP3 lof, with a significant increase in NER-deficient lines. The inefficient repair of these lesions increased sub-G1 population of XPA and XPC cells 24 hours after UV treatment, notably marked by DUSP3 lof, which is associated with a reduced cell population in G1, S and G2/M phases. It was also detected an increase in S and G2/M populations of XPV and MRC-5 cells after UV-radiation exposure, which was slightly attenuated by DUSP3 lof due to a discrete increase in sub-G1 cells. The cell cycle progression was accompanied by changes in the levels of the main Cyclins (A1, B1, D1 or E1), CDKs (1, 2, 4 or 6), and the p21 Cip1 inhibitor, in a DUSP3-dependent manner. DUSP3 lof affected the proliferation of MRC-5 and XPA cells, with marked worsening of the XP phenotype after UV radiation. This work highlights the roles of DUSP3 in DNA repair fitness and in the fine control of regulatory proteins of cell cycle, essential mechanisms to maintenance of genomic stability.


  • Open Access

    A metal-free blue chromophore derived from plant pigments

    by B. C. Freitas-Dörr, C. O. Machado, A. C. Pinheiro, A. B. Fernandes, F. A. Dörr, E. Pinto, M. Lopes-Ferreira, M. Abdellah, J. Sá, L. C. Russo, et al.

    The red pigments of beets are used to produce BeetBlue, a biocompatible blue dye.


  • Open Access

    Intracellular Peptides in Cell Biology and Pharmacology

    by Christiane B. de Araujo, Andrea S. Heimann, Ricardo A. Remer, Lilian C. Russo, Alison Colquhoun, Fábio L. Forti, Emer S. Ferro

    Intracellular peptides are produced by proteasomes following degradation of nuclear, cytosolic, and mitochondrial proteins, and can be further processed by additional peptidases generating a larger pool of peptides within cells. Thousands of intracellular peptides have been sequenced in plants, yeast, zebrafish, rodents, and in human cells and tissues. Relative levels of intracellular peptides undergo changes in human diseases and also when cells are stimulated, corroborating their biological function. However, only a few intracellular peptides have been pharmacologically characterized and their biological significance and mechanism of action remains elusive. Here, some historical and general aspects on intracellular peptides’ biology and pharmacology are presented. Hemopressin and Pep19 are examples of intracellular peptides pharmacologically characterized as inverse agonists to cannabinoid type 1 G-protein coupled receptors (CB1R), and hemopressin fragment NFKF is shown herein to attenuate the symptoms of pilocarpine-induced epileptic seizures. Intracellular peptides EL28 (derived from proteasome 26S protease regulatory subunit 4; Rpt2), PepH (derived from Histone H2B type 1-H), and Pep5 (derived from G1/S-specific cyclin D2) are examples of peptides that function intracellularly. Intracellular peptides are suggested as biological functional molecules, and are also promising prototypes for new drug development.


  • Functionalized nanoparticles as adjuvant to increase the cytotoxicity of metallodrugs toward tumor cells

    by Eduardo Guimarães Vieira, Rodrigo Bernardi Miguel, Daniel Rodrigues da Silva, Rodrigo Boni Fazzi, Ricardo Alexandre Alves de Couto, Jayr Henrique Marin, Marcia Laudelina Arruda Temperini, Jorge da Silva Shinohara, Henrique Eisi Toma, Lilian Cristina Russo, et al.

    Functionalized MCM-41 is a class of new nanoporous biomaterials extensively studied as drug carriers of a diversity of therapeutic agents due to its suitable properties. In the present study, two oxindolimine complexes based on copper(II) and zinc(II) were immobilized in two selective delivery systems, namely, unmodified and modified MCM-41, which can act as carriers of water-insoluble anticancer metallodrugs. Morphological and structural characterizations of these materials were accomplished, and their cytotoxic effect was evaluated on three different cancer cell lines, SKMEL-147, SKMEL-05 and HeLa, in comparison to a non-tumor cell line (fibroblast P4). Cytotoxicity assays showed that both complexes coordinated to the modified matrix were more active and selective than those immobilized into the unmodified matrix, particularly toward SKMEL-147 cells. In contrast, P4 cells were much less affected by the presence of these compounds, with very high IC50 values. Further, the release of the complexes from these materials was monitored in vitro by X-ray fluorescence, which indicated a significant delivery after 2 h at 37 °C. By using CytoViva™ images, it was possible to observe the presence of such nanoparticles inside the cells, as well as the formation of apoptotic bodies due to the action of these antitumor compounds. A high damage on the nucleus was verified by comet and DNA cleavage assays, pointing to DNA as an important target of such metallodrugs. The matrices also contribute to the potential therapeutic action of these metal complexes, significantly increasing their cytotoxicity against melanoma and cervical carcinoma cells.


  • DUSP3/VHR: A Druggable Dual Phosphatase for Human Diseases

    by Lucas Falcão Monteiro, Pault Yeison Minaya Ferruzo, Lilian Cristina Russo, Jessica Oliveira Farias, Fábio Luís Forti

    Protein tyrosine kinases (PTK), discovered in the 1970s, have been considered master regulators of biological processes with high clinical significance as targets for human diseases. Their actions are countered by protein tyrosine phosphatases (PTP), enzymes yet underrepresented as drug targets because of the high homology of their catalytic domains and high charge of their catalytic pocket. This scenario is still worse for some PTP subclasses, for example, for the atypical dual-specificity phosphatases (ADUSPs), whose biological functions are not even completely known. In this sense, the present work focuses on the dual-specificity phosphatase 3 (DUSP3), also known as VH1-related phosphatase (VHR), an uncommon regulator of mitogen-activated protein kinase (MAPK) phosphorylation. DUSP3 expression and activities are suggestive of a tumor suppressor or tumor-promoting enzyme in different types of human cancers. Furthermore, DUSP3 has other biological functions involving immune response mediation, thrombosis, hemostasis, angiogenesis, and genomic stability that occur through either MAPK-dependent or MAPK-independent mechanisms. This broad spectrum of actions is likely due to the large substrate diversity and molecular mechanisms that are still under scrutiny. The growing advances in characterizing new DUSP3 substrates will allow the development of pharmacological inhibitors relevant for possible future clinical trials. This review covers all aspects of DUSP3, since its gene cloning and crystallographic structure resolution, in addition to its classical and novel substrates and the biological processes involved, followed by an update of what is currently known about the DUSP3/VHR-inhibiting compounds that might be considered potential drugs to treat human diseases.


  • Assessing the Roles of Rho GTPases in Cell DNA Repair by the Nucleotide Excision Repair Pathway

    by Lilian C. Russo, Pault Y. Minaya, Luiz E. Silva, Fábio L. Forti

    Ultraviolet light crossing the ozone layer in the atmospheric barrier affects all forms of living beings on earth. In eukaryotic cells, the nucleotide excision repair (NER) pathway protects the DNA by removing cyclobutane pyrimidine dimers (CPDs) and 6–4-photoproduct (6–4-PP) lesions caused by ultraviolet (UV) light, allowing cells to proliferate. On the other hand, adhesion and invasion processes, primarily regulated by the typical Rho GTPases Rho, Rac, and Cdc42, are also affected by UV radiation effects. Studies focused on determining whether or not these GTPases might affect the NER pathway in different cell models are enlightening and should start with classical experimental methodologies. In this chapter we describe two methods (host cell reactivation assay, or HCR, and slot-blots for CPDs and 6–4-PPs) to assess the direct or indirect involvement of these three GTPases on the NER pathway.


  • Open Access

    Revisiting the roles of VHR/DUSP3 phosphatase in human diseases

    by Lilian Cristina Russo, Jéssica Oliveira Farias, Pault Yeison Minaya Ferruzo, Lucas Falcão Monteiro, Fábio Luís Forti

    Protein tyrosine phosphatases have long been considered key regulators of biological processes and are therefore implicated in the origins of various human diseases. Heterozygosity, mutations, deletions, and the complete loss of some of these enzymes ...


  • Loss of DUSP3 activity radiosensitizes human tumor cell lines via attenuation of DNA repair pathways

    by Thompson E.P. Torres, Lilian C. Russo, Alexsandro Santos, Gabriela R. Marques, Yuli T. Magalhaes, Sartaj Tabassum, Fabio L. Forti